dr. rosenberg on dosing of nivolumab plus ipilimumab in bladder cancer
Published 5 years ago • 267 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:21
dr. rosenberg on immunotherapeutic advances in bladder cancer
-
1:20
dr. rosenberg on future use of atezolizumab in bladder cancer
-
0:43
dr. rosenberg on frontline immunotherapy potential in bladder cancer
-
2:03
dr. rosenberg on enfortumab vedotin/pembrolizumab in urothelial carcinoma
-
0:43
dr. rosenberg discusses the importance of clinical trials in bladder cancer
-
1:13
dr. rosenberg on immunotherapy in non-metastatic muscle invasive bladder cancer
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
1:20
dr. rosenberg on non-metastatic muscle invasive bladder cancer guidelines
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:03
dr. sklar on the role of nivolumab in bladder cancer
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
1:38
dr. rosenberg discuss challenges in metastatic urothelial carcinoma
-
1:45
dr. rosenberg on the keynote-045 trial in advanced urothelial cancer
-
1:07
dr. galsky on ipilimumab in bladder cancer
-
1:56
nivolumab and ipilimumab for advanced bcvh
-
1:08
future treatment approaches for patients with bladder cancer
-
1:30
dr. poch on nivolumab as a treatment for patients with bladder cancer
-
1:58
phase ii trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies
-
1:50
dr. rosenberg discusses enfortumab vedotin in urothelial carcinoma